Accelerating Complex Biomarkers, Novel & Multimodal Endpoints to Fuel Drug-Diagnostic Innovations from Bench-to-Bedside for Global Precision Medicine Access
With the FDA’s LDT and 510(k) regulatory recalibration now easing long‑standing hesitation and bottlenecks in drug‑diagnostic approvals, we are entering a defining new chapter for precision medicine. What began as tentative regulatory shifts in mid-2025 has now reshaped the entire translational, clinical, and commercial landscape:
- Accelerated synchronized Rx-Dx launches, the rise of ctDNA and MRD endpoints
- Expanded coverage for advanced genomic tests,
- Explosion of innovation across digital pathology, spatial omics, multimodal analytics, and agentic‑AI diagnostic platforms, as evidenced by over $60B in diagnostic deal-making and partnerships.
Powered by these tailwinds, the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns as the longest‑standing, end‑to‑end precision medicine meeting, uniting 800+ senior stakeholders across biopharma, diagnostic, regulatory, healthcare, testing labs, and multimodal communities.
In 2026, this cornerstone summit expands to five dedicated content tracks, reflecting the complexity and acceleration of novel endpoints and IVD innovation.
This forum is an industry targeted event with a very specific focus, I appreciate that this has stayed consistent for the precision medicine community over the years.
Global Director, Amgen
A great opportunity to network with professionals in the companion diagnostics field and stay updated on the latest trends, emerging technologies and regulatory challenges.
Director, Translational Medicine, AstraZeneca
This forum forges the opportunity to 1) meet diverse group of individuals and organizations working in the CDx space 2) hear about ongoing efforts, challenges and wins, 3) meet key vendors working in the biomarker and CDx space.
Head of Translational Medicine, Pfizer
Register your Interest for 2026
- Free* to Attend for Biopharma & Academia
- The Globes Leading Biomarker & Companion Diagnostic Forum
- Strategic Rx-Dx Co-Development & Partnership Selection Panels
- Biomarker panels in Oncology, Haematology, Neurological, Chronic, Autoimmune, & Rare Disease
- Brand New Case Studies on Digital Pathology, Multimodal Data and AI-Enabled Precision Medicine
- Exclusive Networking & Partnerships Opportunities
Expertise Partners Included
Explore Related Events
Explore the Agenda
Hear the latest translational, clinical and post-approval breakthroughs and gain exclusive insights into precision medicine innovations during our packed agenda, interactive roundtables, and new drug-diagnostic partnerships panel discussions
Partner With Us
Position yourself alongside other leading IVD and CDx solution providers to ensure your brand is at the heart of precision medicines deals and collaborations
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning a range of precision therapy modalities and indications, and make critical connections during our dedicated networking sessions